1. Home
  2. ENGN vs AMRN Comparison

ENGN vs AMRN Comparison

Compare ENGN & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENGN
  • AMRN
  • Stock Information
  • Founded
  • ENGN 1999
  • AMRN 1989
  • Country
  • ENGN Canada
  • AMRN Ireland
  • Employees
  • ENGN N/A
  • AMRN N/A
  • Industry
  • ENGN
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ENGN
  • AMRN Health Care
  • Exchange
  • ENGN Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • ENGN 191.1M
  • AMRN 216.0M
  • IPO Year
  • ENGN N/A
  • AMRN 1993
  • Fundamental
  • Price
  • ENGN $4.32
  • AMRN $15.98
  • Analyst Decision
  • ENGN Buy
  • AMRN Strong Sell
  • Analyst Count
  • ENGN 7
  • AMRN 1
  • Target Price
  • ENGN $23.29
  • AMRN $12.00
  • AVG Volume (30 Days)
  • ENGN 102.1K
  • AMRN 69.5K
  • Earning Date
  • ENGN 09-09-2025
  • AMRN 07-30-2025
  • Dividend Yield
  • ENGN N/A
  • AMRN N/A
  • EPS Growth
  • ENGN N/A
  • AMRN N/A
  • EPS
  • ENGN N/A
  • AMRN N/A
  • Revenue
  • ENGN N/A
  • AMRN $219,361,000.00
  • Revenue This Year
  • ENGN N/A
  • AMRN N/A
  • Revenue Next Year
  • ENGN N/A
  • AMRN N/A
  • P/E Ratio
  • ENGN N/A
  • AMRN N/A
  • Revenue Growth
  • ENGN N/A
  • AMRN N/A
  • 52 Week Low
  • ENGN $2.65
  • AMRN $7.08
  • 52 Week High
  • ENGN $11.00
  • AMRN $17.49
  • Technical
  • Relative Strength Index (RSI)
  • ENGN 70.93
  • AMRN 59.78
  • Support Level
  • ENGN $3.52
  • AMRN $15.54
  • Resistance Level
  • ENGN $3.89
  • AMRN $16.50
  • Average True Range (ATR)
  • ENGN 0.27
  • AMRN 0.48
  • MACD
  • ENGN 0.05
  • AMRN 0.08
  • Stochastic Oscillator
  • ENGN 90.94
  • AMRN 73.06

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: